Long-term follow-up as an indispensable parameter for reliable assessment of the audiologic outcome after middle ear surgery

Author(s):  
Konstantinos Mantsopoulos ◽  
Vivian Thimsen ◽  
Miguel Goncalves ◽  
Matti Sievert ◽  
Sarina Katrin Müller ◽  
...  
1981 ◽  
Vol 74 (5special) ◽  
pp. 913-920
Author(s):  
Kotaro Ukai ◽  
Yasuro Miyoshi ◽  
Yasuo Sakakura ◽  
Mikikazu Yamagiwa ◽  
Yuichi Majima ◽  
...  

2001 ◽  
Vol 111 (11) ◽  
pp. 2064-2070 ◽  
Author(s):  
Takehisa Saito ◽  
Yasuhiro Manabe ◽  
Yoshiyuki Shibamori ◽  
Takahiro Yamagishi ◽  
Hideki Igawa ◽  
...  

2021 ◽  
pp. 000348942110254
Author(s):  
Sara E. Henkemans ◽  
Adriana L. Smit ◽  
Robert J. Stokroos ◽  
Hans G.X.M. Thomeer

Objectives: In this study, we aim to analyze audiometric outcomes of middle ear surgery in patients with congenital middle ear anomalies. Methods: In this single center retrospective cohort study, audiological outcomes were extracted from patient files. Patients with a congenital middle ear anomaly treated surgically in a tertiary referral center between June 2015 and December 2020 were included. Pre- and postoperative short- and long-term audiometric data (at ≥3 and ≥10 months respectively) were compared to analyze hearing outcomes. Results: Eighteen ears (15 patients) were treated surgically with an exploratory tympanotomy. At short term follow up statistically significant improvements in air conduction thresholds and air-bone gaps were found. Hearing improved in 94.4% (17/18) of operated ears. Successful outcome, defined as an air-bone gap closure to within 20 dB after surgery, was reached in 44.4% (8/18). Serviceable hearing (air conduction ≤30 dB) was reached in 55.6% (10/18). Negative outcome (any significant deterioration in hearing) occurred in 1 patient: in this ear otitis media occurred during the postoperative course. At long term follow up, available for 50% of the cohort, hearing remained stable in 5 ears, improved in 1 ear and deteriorated in 3, all of which underwent revision surgery. Sensorineural hearing loss due to surgery, or other complications, were not encountered. Conclusion: middle ear surgery was found to be an effective treatment option to improve hearing in this cohort of patients with congenital middle ear anomalies. Surgical goals of obtained gain in air conduction thresholds and serviceable hearing levels were met by most patients without the occurrence of any iatrogenic sensorineural hearing loss.


2016 ◽  
Vol 11 (1) ◽  
pp. 89-92
Author(s):  
Dan-Cristian GHEORGHE ◽  
◽  
Adina ZAMFIR-CHIRU-ANTON ◽  
◽  

Objective. To discuss a less common complication of middle ear surgery. Meningoceles are dural herniations that can fill the mastoid cavities through congenital or acquired bony defects of the mastoid walls. They can complicate the postoperative course of surgery for chronic middle ear disease. Material and method. Case presentation showing one patient who developed a mastoid meningocele after extensive cholesteatoma surgery. Discussion. The causes of dural herniation into the mastoid cavities are presented. Some hypothesis regarding the factors that favor the occurrence of this complication are presented. Conclusions. Surgical closing of the bone gap in the mastoid wall was the treatment we used. We can not ascertain yet the long term results of such surgical maneuver, regarding the technique and the graft we used. Attention to the mastoid surgical detail and good postoperative intensive care could prevent such complications.


1983 ◽  
Vol 91 (4) ◽  
pp. 437-440 ◽  
Author(s):  
Steven D. Handler ◽  
William P. Potsic ◽  
Roger R. Marsh

A prospective controlled pilot study was undertaken in which Biolite (carbon-coated) ventilation tubes were placed in 44 ears and a conventional silicone tube in the contralateral ear. Long-term follow-up of these patients has revealed little difference in the incidence of tube occlusion or early extrusion. In addition, there were several disadvantages noted with the Biolite tubes: incomplete coating of the tube (especially within the lumen), shedding of the Biolite coating over time, “tattooing” of the tympanic membrane, poor otoscopic visibility, and the higher cost of these tubes. Since the Biolite tube has no documented advantages and, actually, several disadvantages, we believe its use in the treatment of middle ear disorders should be discontinued until significant benefits are demonstrated and present deficiencies are corrected.


Sign in / Sign up

Export Citation Format

Share Document